Woodford suffers second hit in as many days

AstraZeneca’s share price fall is a timely reminder of how volatile the healthcare sector can be. Ketan Patel, fund manager at EdenTree Investment Management, explores the dilemma facing investors in FT Adviser: do they continue to back the management team or redeploy their funds into another name in the sector.

Link

top